
Mounjaro Becomes 2nd Diabetes Drug Prescribed for Weight Loss on NHS
Published on June 5, 2024
The self-injected drug Mounjaro has become the second diabetes medication to be recommended to help obese people lose weight on the UK’s National Health Service (NHS). The drug was recommended last September by the National Institute for Health and Care Excellence (NICE) for type 2 diabetics who could not tolerate other drugs owing to side-effects. At the time, the NHS said it would need “more evidence” before it would greenlight its use for weight loss. The latest draft guidance from NICE, published this week, says the drug should now be an option to help people lose weight, following its approval as an anti-obesity treatment by the Medicines and Healthcare products Regulatory Agency (MHRA) last November....
